[The hypereosinophilic syndrome]

Ann Dermatol Venereol. 2003 Jun-Jul;130(6-7):664-6.
[Article in French]
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Administration, Oral
  • Adrenal Cortex Hormones / administration & dosage
  • Adrenal Cortex Hormones / therapeutic use
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / therapeutic use
  • Diagnosis, Differential
  • Humans
  • Hydroxyurea / administration & dosage
  • Hydroxyurea / therapeutic use
  • Hypereosinophilic Syndrome* / classification
  • Hypereosinophilic Syndrome* / complications
  • Hypereosinophilic Syndrome* / diagnosis
  • Hypereosinophilic Syndrome* / drug therapy
  • Hypereosinophilic Syndrome* / etiology
  • Immunologic Factors / administration & dosage
  • Immunologic Factors / therapeutic use
  • Interferon-alpha / administration & dosage
  • Interferon-alpha / therapeutic use
  • Risk Factors
  • Skin Diseases / diagnosis
  • Skin Diseases / etiology

Substances

  • Adrenal Cortex Hormones
  • Antineoplastic Agents
  • Immunologic Factors
  • Interferon-alpha
  • Hydroxyurea